Beyond Ozempic? New Weight Loss Drug Shows Stunning Results in Major Clinical Trial
4 Articles
4 Articles
Beyond Ozempic? New Weight Loss Drug Shows Stunning Results in Major Clinical Trial
Retatrutide could help tackle obesity and type 2 diabetes together, with an 80-week trial showing substantial weight loss and better blood sugar control alongside more nausea and diarrhea. A weekly injection beneath the skin helped adults with excess weight and type 2 diabetes lose nearly a fifth of their starting weight, on average, at the [...]
New drug retatrutide allowed diabetic patients to lose up to 18.8% of their weight and improve blood sugar levels in 80 weeks, but caused nausea
The world of pharmaceutical medicine is witnessing a new major milestone that could surpass all previous achievements in the treatment of metabolic diseases. After drugs like Ozempic and Mounjar brought a real revolution in the treatment of obesity and diabetes, the latest results of an extensive study published in the prestigious medical journal The Lancet show that an even more powerful therapeutic tool is coming. It is about retatrutide, a ne…
A recent study has shown that retatrutide, a new drug, can be effective in treating obesity and type 2 diabetes. The results of the clinical trial TRIUMPH-2, which lasted 80 weeks, showed...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
